iShares Biotechnology ETF (NASDAQ:IBB) Stock Holdings Lessened by Wells Fargo & Company MN

Wells Fargo & Company MN cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 13.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 679,796 shares of the financial services provider’s stock after selling 103,550 shares during the quarter. Wells Fargo & Company MN’s holdings in iShares Biotechnology ETF were worth $89,876,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. FMR LLC increased its position in shares of iShares Biotechnology ETF by 19.2% in the third quarter. FMR LLC now owns 14,450 shares of the financial services provider’s stock worth $2,104,000 after acquiring an additional 2,332 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter worth approximately $2,941,000. Benjamin Edwards Inc. purchased a new position in iShares Biotechnology ETF during the 3rd quarter worth approximately $244,000. Quantinno Capital Management LP acquired a new stake in iShares Biotechnology ETF during the 3rd quarter valued at $244,000. Finally, Kovitz Investment Group Partners LLC lifted its holdings in shares of iShares Biotechnology ETF by 38.0% in the third quarter. Kovitz Investment Group Partners LLC now owns 4,192 shares of the financial services provider’s stock valued at $610,000 after purchasing an additional 1,154 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.8 %

Shares of iShares Biotechnology ETF stock opened at $116.21 on Tuesday. iShares Biotechnology ETF has a 12 month low of $111.23 and a 12 month high of $150.57. The stock has a market cap of $5.24 billion, a PE ratio of 24.21 and a beta of 0.84. The business has a fifty day simple moving average of $134.51 and a 200-day simple moving average of $137.81.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. The ex-dividend date was Tuesday, March 18th. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.